Drugs / Vistabel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01014871 | Jul 2009 → Apr 2010 | — | Galderma R&D | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vistabel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01014871 ↗ |
| Known as | Botox | “There are two formulations of BoNT-A available: Botox®/Vistabel®, Allergan and Dysport®/Azzalure®, Ipsen - Galderma” NCT01014871 ↗ |